Cargando…
Prognosis of AKI in malignant diseases with and without sepsis
BACKGROUND: AKI significantly worsens prognosis of hospitalized patients. This is particularly the case in patients with sepsis. The risk for aquiring sepsis is significantly increased in malignant diseases. Aim of the present retrospective study was to analyze outcomes of tumor patients with sepsis...
Autores principales: | Heeg, Malte, Mertens, Alexander, Ellenberger, David, Müller, Gerhard A, Patschan, Daniel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4175479/ https://www.ncbi.nlm.nih.gov/pubmed/24168374 http://dx.doi.org/10.1186/1471-2253-13-36 |
Ejemplares similares
-
CD4(+) lymphocyte adenosine triphosphate - a new marker in sepsis with acute kidney injury?
por: Patschan, Daniel, et al.
Publicado: (2014) -
Endothelial autophagy and Endothelial-to-Mesenchymal Transition (EndoMT) in eEPC treatment of ischemic AKI
por: Patschan, Daniel, et al.
Publicado: (2015) -
Endothelial Colony Forming Cells (ECFCs) in murine AKI – implications for future cell-based therapies
por: Patschan, D., et al.
Publicado: (2017) -
PAC-Mediated AKI Protection Is Critically Mediated but Does Not Exclusively Depend on Cell-Derived Microvesicles
por: Dihazi, H., et al.
Publicado: (2021) -
Angiopoietin-1 treated early endothelial outgrowth cells (eEOCs) are activated in vitro and reduce renal damage in murine acute ischemic kidney injury (iAKI)
por: Patschan, Daniel, et al.
Publicado: (2013)